These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 32100930)
1. Nutritional status in tricuspid regurgitation: implications of transcatheter repair. Besler C; Unterhuber M; Rommel KP; Unger E; Hartung P; von Roeder M; Noack T; Zachäus M; Halm U; Borger M; Desch S; Thiele H; Lurz P Eur J Heart Fail; 2020 Oct; 22(10):1826-1836. PubMed ID: 32100930 [TBL] [Abstract][Full Text] [Related]
2. Transcatheter Edge-to-Edge Tricuspid Repair for Severe Tricuspid Regurgitation Reduces Hospitalizations for Heart Failure. Orban M; Rommel KP; Ho EC; Unterhuber M; Pozzoli A; Connelly KA; Deseive S; Besler C; Ong G; Braun D; Edwards J; Miura M; Gülmez G; Stolz L; Gavazzoni M; Zuber M; Orban M; Nabauer M; Maisano F; Thiele H; Massberg S; Taramasso M; Fam NP; Lurz P; Hausleiter J JACC Heart Fail; 2020 Apr; 8(4):265-276. PubMed ID: 32241534 [TBL] [Abstract][Full Text] [Related]
3. Predictors of Procedural and Clinical Outcomes in Patients With Symptomatic Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair. Besler C; Orban M; Rommel KP; Braun D; Patel M; Hagl C; Borger M; Nabauer M; Massberg S; Thiele H; Hausleiter J; Lurz P JACC Cardiovasc Interv; 2018 Jun; 11(12):1119-1128. PubMed ID: 29929631 [TBL] [Abstract][Full Text] [Related]
4. Impact of Transcatheter Tricuspid Valve Repair for Severe Tricuspid Regurgitation on Kidney and Liver Function. Karam N; Braun D; Mehr M; Orban M; Stocker TJ; Deseive S; Orban M; Hagl C; Näbauer M; Massberg S; Hausleiter J JACC Cardiovasc Interv; 2019 Aug; 12(15):1413-1420. PubMed ID: 31126888 [TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics and Outcomes of Patients Screened for Transcatheter Tricuspid Valve Replacement: The TriACT Registry. Hagemeyer D; Merdad A; Sierra LV; Ruberti A; Kargoli F; Bouchat M; Boiago M; Moschovitis A; Deva DP; Stolz L; Ong G; Peterson MD; Piazza N; Taramasso M; Dumonteil N; Modine T; Latib A; Praz F; Hausleiter J; Fam NP JACC Cardiovasc Interv; 2024 Feb; 17(4):552-560. PubMed ID: 38418058 [TBL] [Abstract][Full Text] [Related]
6. Long-Term Outcomes of the FORMA Transcatheter Tricuspid Valve Repair System for the Treatment of Severe Tricuspid Regurgitation: Insights From the First-in-Human Experience. Asmarats L; Perlman G; Praz F; Hensey M; Chrissoheris MP; Philippon F; Ofek H; Ye J; Puri R; Pibarot P; Attinger A; Moss R; Bédard E; Moschovitis A; Reineke D; Lauck S; Blanke P; Leipsic J; Spargias K; Windecker S; Webb JG; Rodés-Cabau J JACC Cardiovasc Interv; 2019 Aug; 12(15):1438-1447. PubMed ID: 31395213 [TBL] [Abstract][Full Text] [Related]
7. Physiological and Clinical Consequences of Right Ventricular Volume Overload Reduction After Transcatheter Treatment for Tricuspid Regurgitation. Rommel KP; Besler C; Noack T; Blazek S; von Roeder M; Fengler K; Ender J; Gutberlet M; Desch S; Borger MA; Thiele H; Lurz P JACC Cardiovasc Interv; 2019 Aug; 12(15):1423-1434. PubMed ID: 31326430 [TBL] [Abstract][Full Text] [Related]
8. Health Status After Transcatheter Tricuspid Valve Repair in Patients With Functional Tricuspid Regurgitation. Kitamura M; Kresoja KP; Balata M; Besler C; Rommel KP; Unterhuber M; Lurz J; Rosch S; Gunold H; Noack T; Thiele H; Lurz P JACC Cardiovasc Interv; 2021 Dec; 14(23):2545-2556. PubMed ID: 34887048 [TBL] [Abstract][Full Text] [Related]
9. Cardiopulmonary Hemodynamic Profile Predicts Mortality After Transcatheter Tricuspid Valve Repair in Chronic Heart Failure. Stocker TJ; Hertell H; Orban M; Braun D; Rommel KP; Ruf T; Ong G; Nabauer M; Deseive S; Fam N; von Bardeleben RS; Thiele H; Massberg S; Lurz P; Hausleiter J JACC Cardiovasc Interv; 2021 Jan; 14(1):29-38. PubMed ID: 33309317 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair. Lurz P; Orban M; Besler C; Braun D; Schlotter F; Noack T; Desch S; Karam N; Kresoja KP; Hagl C; Borger M; Nabauer M; Massberg S; Thiele H; Hausleiter J; Rommel KP Eur Heart J; 2020 Aug; 41(29):2785-2795. PubMed ID: 32176280 [TBL] [Abstract][Full Text] [Related]
11. Six-month outcome after transcatheter edge-to-edge repair of severe tricuspid regurgitation in patients with heart failure. Orban M; Besler C; Braun D; Nabauer M; Zimmer M; Orban M; Noack T; Mehilli J; Hagl C; Seeburger J; Borger M; Linke A; Thiele H; Massberg S; Ender J; Lurz P; Hausleiter J Eur J Heart Fail; 2018 Jun; 20(6):1055-1062. PubMed ID: 29405554 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary capillary wedge pressure (PCWP) as prognostic indicator in patients undergoing transcatheter valve repair (TTVR) of severe tricuspid regurgitation. Kavsur R; Hupp H; Sugiura A; Öztürk C; Weber M; Nickenig G; Tiyerili V; Becher MU Int J Cardiol; 2020 Nov; 318():32-38. PubMed ID: 32598993 [TBL] [Abstract][Full Text] [Related]
13. Right ventricular remodeling and clinical outcomes following transcatheter tricuspid valve intervention. Dershowitz L; Lawlor MK; Hamid N; Kampaktsis P; Ning Y; Vahl TP; Nazif T; Khalique O; Ng V; Kurlansky P; Leon M; Hahn R; Kodali S; George I Catheter Cardiovasc Interv; 2024 Feb; 103(2):367-375. PubMed ID: 37890014 [TBL] [Abstract][Full Text] [Related]
14. Combined Mitral and Tricuspid Versus Isolated Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Symptomatic Valve Regurgitation at High Surgical Risk. Besler C; Blazek S; Rommel KP; Noack T; von Roeder M; Luecke C; Seeburger J; Ender J; Borger MA; Linke A; Gutberlet M; Thiele H; Lurz P JACC Cardiovasc Interv; 2018 Jun; 11(12):1142-1151. PubMed ID: 29929635 [TBL] [Abstract][Full Text] [Related]
15. 12-Month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitation. Kitamura M; Fam NP; Braun D; Ruf T; Sugiura A; Narang A; Connelly KA; Ho E; Nabauer M; Hausleiter J; Weber M; Nickenig G; Davidson CJ; Thiele H; von Bardeleben RS; Lurz P Catheter Cardiovasc Interv; 2021 May; 97(6):1281-1289. PubMed ID: 33660364 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the get with the guidelines-heart failure (GWTG-HF) risk score in patients undergoing trans-catheter tricuspid valve repair (TTVR). Kavsur R; Hupp-Herschel HE; Sugiura A; Tanaka T; Öztürk C; Weber M; Nickenig G; Tiyerili V; Becher MU Heart Vessels; 2021 Dec; 36(12):1903-1910. PubMed ID: 34023969 [TBL] [Abstract][Full Text] [Related]
17. Early and mid-term outcomes of transcatheter tricuspid valve repair: systematic review and meta-analysis of observational studies. Alperi A; Avanzas P; Almendárez M; León V; Hernández-Vaquero D; Silva I; Fernández Del Valle D; Fernández F; Díaz R; Rodes-Cabau J; Morís C; Pascual I Rev Esp Cardiol (Engl Ed); 2023 May; 76(5):322-332. PubMed ID: 35662675 [TBL] [Abstract][Full Text] [Related]
18. Cardiac output states in patients with severe functional tricuspid regurgitation: impact on treatment success and prognosis. Unterhuber M; Kresoja KP; Besler C; Rommel KP; Orban M; von Roeder M; Braun D; Stolz L; Massberg S; Trebicka J; Zachäus M; Hausleiter J; Thiele H; Lurz P Eur J Heart Fail; 2021 Oct; 23(10):1784-1794. PubMed ID: 34272792 [TBL] [Abstract][Full Text] [Related]
19. Transcatheter tricuspid valve repair in the setting of heart failure with preserved or reduced left ventricular ejection fraction. Kresoja KP; Lauten A; Orban M; Rommel KP; Alushi B; Besler C; Braun D; Unterhuber M; Stangl K; Landmesser U; Massberg S; Thiele H; Hausleiter J; Lurz P Eur J Heart Fail; 2020 Oct; 22(10):1817-1825. PubMed ID: 32741057 [TBL] [Abstract][Full Text] [Related]